FREE PROMEGA WEBINAR
Date : 11th November 2021
Time : 12 pm (Singapore)/3 pm (Sydney)/1 pm (Seoul)/9.30 am (New Delhi)
Effective therapeutic agents to treat SARS-CoV-2 infection have focused on the interaction of the Spike glycoprotein with the human ACE2 receptor. A new bioluminescent assay enables sensitive measurement of inhibutors to this interaction. In this webinar, our presenter, Dr. Hicham Zegzouti, will summarize studies where the assay is used to detect the presence of neutralizing antibodies from both COVID-19-positive samples and samples from vaccinated individuals. The webinar will include a live Q&A session.⠀
⠀
In this webinar, you will learn how:⠀
– The assay was optimized with known inhibitors of the Spike-ACE2 interaction⠀
– A range of monoclonal antibodies were rank ordered for their effectiveness as inhibitors⠀
– The mthodology shows broad utility and ease of use for both drug discovery and clinical research applications⠀
⠀
FREE Registration Link : https://bit.ly/3CHaEC8
